145 related articles for article (PubMed ID: 6112153)
21. Characterization of solubilized dopamine receptors from dog striatum.
Gorissen H; Aerts G; Laduron P
FEBS Lett; 1979 Apr; 100(2):281-5. PubMed ID: 37113
[No Abstract] [Full Text] [Related]
22. Neuroleptics have identical potencies in human brain limbic and putamen regions.
Seeman P; Ulpian C
Eur J Pharmacol; 1983 Oct; 94(1-2):145-8. PubMed ID: 6140171
[TBL] [Abstract][Full Text] [Related]
23. Neuroleptic binding and their effects on the spontaneous and potassium-evoked release of 3H-dopamine from the striatum and of 3H-noradrenaline from the cerebral cortex.
Arbilla S; Briley MS; Dubocovich ML; Langer SZ
Life Sci; 1978 Oct; 23(17-18):1775-80. PubMed ID: 31532
[No Abstract] [Full Text] [Related]
24. Dopamine receptor binding of a novel dibenzodioxazocine derivative, EGYT-2509.
Gyüre K; Szentendrei T; Kanyicska B; Fekete MI; Rónai AZ
Pol J Pharmacol Pharm; 1985; 37(3):253-61. PubMed ID: 2866498
[TBL] [Abstract][Full Text] [Related]
25. Characteristics of [3H]sultopride binding to rat brain.
Mizuchi A; Kitagawa N; Saruta S; Miyachi Y
Eur J Pharmacol; 1982 Oct; 84(1-2):51-9. PubMed ID: 6128237
[TBL] [Abstract][Full Text] [Related]
26. The low affinity component of [3H]spiperone binding reflects association to a non-dopaminergic, neuroleptic site.
Beart PM; Krstich M; McDonald D; Gundlach AL
Neurosci Lett; 1982 Apr; 29(2):147-51. PubMed ID: 6123968
[TBL] [Abstract][Full Text] [Related]
27. Prolonged inhibition of striatal dopamine receptor sites by isofloxythepin.
Lau YS; Runice C
Eur J Pharmacol; 1985 Oct; 116(1-2):25-31. PubMed ID: 2865162
[TBL] [Abstract][Full Text] [Related]
28. Comparison of dopamine receptor sites labeled by [3H]-S-sulpiride and [3H]-spiperone in striatum.
Zahniser NR; Dubocovich ML
J Pharmacol Exp Ther; 1983 Dec; 227(3):592-9. PubMed ID: 6655559
[TBL] [Abstract][Full Text] [Related]
29. Characterization of solubilized serotonin (S2) receptors in rat brain.
Ilien B; Gorissen H; Laduron PM
Mol Pharmacol; 1982 Sep; 22(2):243-9. PubMed ID: 7144728
[TBL] [Abstract][Full Text] [Related]
30. Comparison of (3H)-terguride and (3H)-spiperone binding to dopamine receptors in the rat striatum.
Valchár M; Dobrovský K; Krejcí I; Dlabac A
Act Nerv Super (Praha); 1989 Apr; 31(1):77-9. PubMed ID: 2675526
[No Abstract] [Full Text] [Related]
31. Improvement in conditions for solubilisation and characterisation of brain D2 dopamine receptors using various detergents.
Wheatley M; Hall JM; Frankham PA; Strange PG
J Neurochem; 1984 Oct; 43(4):926-34. PubMed ID: 6470714
[TBL] [Abstract][Full Text] [Related]
32. Elevation of brain neuroleptic/dopamine receptors in schizophrenia.
Lee T; Seeman P
Am J Psychiatry; 1980 Feb; 137(2):191-7. PubMed ID: 6101525
[TBL] [Abstract][Full Text] [Related]
33. Selective and stereospecific interactions of R-SK & F 38393 with [3H]piflutixol but not [3H]spiperone binding to striatal D1 and D2 dopamine receptors: comparisons with SCH 23390.
O'Boyle KM; Waddington JL
Eur J Pharmacol; 1984 Mar; 98(3-4):433-6. PubMed ID: 6144559
[TBL] [Abstract][Full Text] [Related]
34. Differential affinities of molindone, metoclopramide and domperidone for classes of [3H]spiroperidol binding sites in rat striatum: evidence for pharmacologically distinct classes of receptors.
Rosenfeld MR; Dvorkin B; Klein PN; Makman MH
Brain Res; 1982 Mar; 235(1):205-11. PubMed ID: 6145486
[TBL] [Abstract][Full Text] [Related]
35. Long-term adaptive changes in striatal dopamine function in response to chronic neuroleptic intake in rats.
Jenner P; Kerwin R; Rupniak NM; Murugaiah K; Hall MD; Fleminger S; Marsden CD
J Neural Transm Suppl; 1983; 18():205-12. PubMed ID: 6135741
[TBL] [Abstract][Full Text] [Related]
36. Resolution of dopamine and serotonin receptor components of [3H]spiperone binding to rat brain regions.
List SJ; Seeman P
Proc Natl Acad Sci U S A; 1981 Apr; 78(4):2620-4. PubMed ID: 6941314
[TBL] [Abstract][Full Text] [Related]
37. Photoaffinity labelling of dopamine D2 receptors by [3H]azidomethylspiperone.
Niznik HB; Grigoriadis DE; Seeman P
FEBS Lett; 1986 Dec; 209(1):71-6. PubMed ID: 2948835
[TBL] [Abstract][Full Text] [Related]
38. Dopamine denervation does not alter in vivo 3H-spiperone binding in rat striatum: implications for external imaging of dopamine receptors in Parkinson's disease.
Bennett JP; Wooten GF
Ann Neurol; 1986 Apr; 19(4):378-83. PubMed ID: 3707090
[TBL] [Abstract][Full Text] [Related]
39. [3H]spiperone binds selectively to rat striatal D2 dopamine receptors in vivo: a kinetic and pharmacological analysis.
Leslie CA; Bennett JP
Brain Res; 1987 Mar; 407(2):253-62. PubMed ID: 2952221
[TBL] [Abstract][Full Text] [Related]
40. In vivo [3H]spiperone binding: evidence for accumulation in corpus striatum by agonist-mediated receptor internalization.
Chugani DC; Ackermann RF; Phelps ME
J Cereb Blood Flow Metab; 1988 Jun; 8(3):291-303. PubMed ID: 2966803
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
